| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |